Temporal pattern of left ventricular structural and functional remodeling following reversal of volume overload heart failure

Journal of Applied Physiology

Volumn 111, Issue 6, 2011, Pages 1778-1788

  Hutchinson, Kirk R ^a,b   Guggilam, Anuradha ^a,c   Cismowski, Mary J ^a,c   Galantowicz, Maarten L ^a   West, Thomas A ^a   Stewart Jr , James A ^a,c   Zhang, Xiaojin ^a   Lord, Kevin C ^d   Lucchesi, Pamela A ^a,c  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF THE INCARNATE WORD   (United States)

Author keywords

Cardiac remodeling hypertrophy; Collagen; Hemodynamics

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; COLLAGEN; MESSENGER RNA; MYOSIN HEAVY CHAIN; SCLEROPROTEIN;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; FIBROSIS; GENETICS; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HEART VOLUME; MALE; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BASE SEQUENCE; CARDIAC VOLUME; COLLAGEN; EXTRACELLULAR MATRIX PROTEINS; FIBROSIS; HEART FAILURE; MALE; MODELS, CARDIOVASCULAR; MYOSIN HEAVY CHAINS; NATRIURETIC PEPTIDE, BRAIN; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 80055043083     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00691.2011     Document Type: Article

References (36)

1. Abraham WT. Cardiac resynchronization therapy. Progr Cardiovasc Dis 48: 232-238, 2006. (Pubitemid 43326299)
2. Acker MA, Bolling S, Shemin R, Kirklin J, Oh JK, Mann DL, Jessup M, Sabbah HN, Starling RC, Kubo SH. Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial. J Thorac Cardiovasc Surg 132: 568-577, 577.e561-564, 2006.
3. Ahmed MI, Gladden JD, Litovsky SH, Lloyd SG, Gupta H, Inusah S, Denney T Jr, Powell P, McGiffin DC, Dell'Italia LJ. Increased oxidative stress and cardiomyocyte myofibrillar degeneration in patients with chronic isolated mitral regurgitation and ejection fraction -60%. J Am Coll Cardiol 55: 671-679, 2010.
4. Baba HA, Wohlschlaeger J. Morphological and molecular changes of the myocardium after left ventricular mechanical support. Curr Cardiol Rev 4: 157-169, 2008.
5. Brower GL, Henegar JR, Janicki JS. Temporal evaluation of left ventricular remodeling and function in rats with chronic volume overload. Am J Physiol Heart Circ Physiol 271: H2071-H2078, 1996.
6. Burkhoff D, Mirsky I, Suga H. Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol 289: H501-H512, 2005. (Pubitemid 41129360)
7. Carabello BA. The current therapy for mitral regurgitation. J Am Coll Cardiol 52: 319-326, 2008. (Pubitemid 352002859)
8. Castellant P, Fatemi M, Bertault-Valls V, Etienne Y, Blanc JJ. Cardiac resynchronization therapy: "nonresponders" and " hyperresponders". Heart Rhythm 5: 193-197, 2008. (Pubitemid 351168543)
9. Cavallero S, Gonzalez GE, Puyo AM, Roson MI, Perez S, Morales C, Hertig CM, Gelpi RJ, Fernandez BE. Atrial natriuretic peptide behaviour and myocyte hypertrophic profile in combined pressure and volumeinduced cardiac hypertrophy. J Hypertens 25: 1940-1950, 2007. (Pubitemid 47356636)
10. Chen YW, Pat B, Gladden JD, Zheng J, Powell P, Wei CC, Cui X, Husain A, Dell'italia LJ. Dynamic molecular and histopathological changes in the extracellular matrix and inflammation in the transition to heart failure in isolated volume overload. Am J Physiol Heart Circ Physiol 300: H2251-H2260, 2011.
11. De Bonis M, Alfieri O. Surgery Insight: surgical methods to reverse left ventricular remodeling. Nat Clin Pract Cardiovasc Med 3: 507-513, 2006. (Pubitemid 44288464)
12. Eapen Z, Rogers JG. Strategies to attenuate pathological remodeling in heart failure. Curr Opin Cardiol 24: 223-229, 2009.
13. Francis GS, Wilson Tang WH. Early cardiac resynchronization therapy and reverse remodeling in patients with mild heart failure: is it time? Circulation 120: 1845-1846, 2009.
14. Garcia R, Diebold S. Simple, rapid, and effective method of producing aortocaval shunts in the rat. Cardiovasc Res 24: 430-432, 1990. (Pubitemid 20179596)
15. Gerdes AM, Clark LC, Capasso JM. Regression of cardiac hypertrophy after closing an aortocaval fistula in rats. Am J Physiol Heart Circ Physiol 268: H2345-H2351, 1995.
16. Hutchinson KR, Stewart JA Jr, Lucchesi PA. Extracellular matrix remodeling during the progression of volume overload-induced heart failure. J Mol Cell Cardiol 48: 564-569, 2010.
17. Kass DA, Beyar R, Lankford E, Heard M, Maughan WL, Sagawa K. Influence of contractile state on curvilinearity of in situ end-systolic pressure-volume relations. Circulation 79: 167-178, 1989. (Pubitemid 19043687)
18. Klotz S, Dickstein ML, Burkhoff D. A computational method of prediction of the end-diastolic pressure-volume relationship by single beat. Nat Protoc 2: 2152-2158, 2007. (Pubitemid 351565853)
19. Komoda T, Komoda S, Dandel M, Weng Y, Hetzer R. Explantation of INCOR left ventricular assist device after myocardial recovery. J Card Surg 23: 642-647, 2008.
20. Krabatsch T, Schweiger M, Dandel M, Stepanenko A, Drews T, Potapov E, Pasic M, Weng YG, Huebler M, Hetzer R. Is bridge to recovery more likely with pulsatile left ventricular assist devices than with nonpulsatile-flow systems? Ann Thorac Surg 91: 1335-1340, 2011.
21. Moilanen AM, Rysa J, Mustonen E, Serpi R, Aro J, Tokola H, Leskinen H, Manninen A, Levijoki J, Vuolteenaho O, Ruskoaho H. Intramyocardial BNP gene delivery improves cardiac function through distinct context-dependent mechanisms. Circ Heart Fail 4: 483-495, 2011.
22. Murakami T, Nakazawa M, Nakanishi T, Momma K. End-systolic wall stress is a major determinant of postoperative left ventricular dysfunction in patients with congenital mitral regurgitation. Cardiol Young 12: 236-239, 2002. (Pubitemid 41238836)
23. Ogletree ML, Sweet WE, Talerico C, Klecka ME, Young JB, Smedira NG, Starling RC, Moravec CS. Duration of left ventricular assist device support: effects on abnormal calcium cycling and functional recovery in the failing human heart. J Heart Lung Transplant 29: 554-561, 2010.
24. Ohba T, Watanabe H, Murakami M, Takahashi Y, Iino K, Kuromitsu S, Mori Y, Ono K, Iijima T, Ito H. Upregulation of TRPC1 in the development of cardiac hypertrophy. J Mol Cell Cardiol 42: 498-507, 2007. (Pubitemid 46349118)
25. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 20: 248-254, 1992.
26. Pearlman AS. Mitral regurgitation: timing of valve surgery. Am Heart Hosp J 5: 48-52, 2007.
27. Reichek N, Wilson J, St John Sutton M., Plappert TA, Goldberg S, Hirshfeld JW. Noninvasive determination of left ventricular end-systolic stress: validation of the method and initial application. Circulation 65: 99-108, 1982. (Pubitemid 12250896)
28. Ryan TD, Rothstein EC, Aban I, Tallaj JA, Husain A, Lucchesi PA, Dell'Italia LJ. Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload. J Am Coll Cardiol 49: 811-821, 2007. (Pubitemid 46240707)
29. Spinale FG, Ishihra K, Zile M, DeFryte G, Crawford FA, Carabello BA. Structural basis for changes in left ventricular function and geometry because of chronic mitral regurgitation and after correction of volume overload. J Thorac Cardiovasc Surg 106: 1147-1157, 1993. (Pubitemid 24018563)
30. St. John Sutton M, Ghio S, Plappert T, Tavazzi L, Scelsi L, Daubert C, Abraham WT, Gold MR, Hassager C, Herre JM, Linde C, and on Behalf of the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction Study Group. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association Class I/II heart failure. Circulation 120: 1858-1865, 2009.
31. Stewart JA Jr, Wei CC, Brower GL, Rynders PE, Hankes GH, Dillon AR, Lucchesi PA, Janicki JS, Dell'Italia LJ. Cardiac mast cell-and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog. J Mol Cell Cardiol 35: 311-319, 2003. (Pubitemid 36379175)
32. Takeda K, Matsumiya G, Sakaguchi T, Miyagawa S, Yamauchi T, Shudo Y, Izutani H, Sawa Y. Impact of untreated mild-to-moderate mitral regurgitation at the time of isolated aortic valve replacement on late adverse outcomes. Eur J Cardiothorac Surg 37: 1033-1038, 2010.
33. Warren CM, Jordan MC, Roos KP, Krzesinski PR, Greaser ML. Titin isoform expression in normal and hypertensive myocardium. Cardiovasc Res 59: 86-94, 2003. (Pubitemid 36776375)
34. Weber KT, Pick R, Silver MA, Moe GW, Janicki JS, Zucker IH, Armstrong PW. Fibrillar collagen and remodeling of dilated canine left ventricle. Circulation 82: 1387-1401, 1990.
35. Weidemann A, Klanke B, Wagner M, Volk T, Willam C, Wiesener MS, Eckardt KU, Warnecke C. Hypoxia, via stabilization of the hypoxiainducible factor HIF-1alpha, is a direct and sufficient stimulus for braintype natriuretic peptide induction. Biochem J 409: 233-242, 2008.
36. Zile MR, Tomita M, Nakano K, Mirsky I, Usher B, Lindroth J, Carabello BA. Effects of left ventricular volume overload produced by mitral regurgitation on diastolic function. Am J Physiol Heart Circ Physiol 261: H1471-H1480, 1991.